Filing Details

Accession Number:
0000950170-25-022648
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-18 19:28:19
Reporting Period:
2025-02-13
Filing Date:
2025-02-18
Accepted Time:
2025-02-18 19:28:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
860730 Hca Healthcare Inc. HCA Services-General Medical & Surgical Hospitals, Nec (8062) 273865930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1793262 Jennifer Berres One Park Plaza
Nashville TN 37203
Svp & Chief Human Res. Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-13 1,588 $0.00 25,352 No 4 A Direct
Common Stock Disposition 2025-02-13 407 $321.92 24,945 No 4 F Direct
Common Stock Disposition 2025-02-14 4,155 $322.96 20,790 No 4 S Direct
Common Stock Disposition 2025-02-14 5,378 $322.31 15,412 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. On January 28, 2022, the reporting person was granted 3,060 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.71 to $323.28, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.70 to $322.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.